In addition, a T2D risk SNP in ANRIL exon 2 was reported to associate with elevated ratios of circular to linear isoforms of ANRIL and was found to reduce pancreatic β-cell proliferation [21]. Here, CDKN2B-AS1 is linked to type 2 diabetes mellitus.